Literature DB >> 18954847

Clinical outcome of patients with heart failure and preserved left ventricular function.

Israel Gotsman1, Donna Zwas, David Planer, Tanya Azaz-Livshits, Dan Admon, Chaim Lotan, Andre Keren.   

Abstract

BACKGROUND: Patients with heart failure have a poor prognosis. However, it has been presumed that patients with heart failure and preserved left ventricular function (LVF) may have a more benign prognosis.
OBJECTIVES: We evaluated the clinical outcome of patients with heart failure and preserved LVF compared with patients with reduced function and the factors affecting prognosis.
METHODS: We prospectively evaluated 289 consecutive patients hospitalized with a definite clinical diagnosis of heart failure based on typical symptoms and signs. They were divided into 2 subsets based on echocardiographic LVF. Patients were followed clinically for a period of 1 year.
RESULTS: Echocardiography showed that more than one third (36%) of the patients had preserved systolic LVF. These patients were more likely to be older and female and have less ischemic heart disease. The survival at 1 year in this group was poor and not significantly different from patients with reduced LVF (75% vs 71%, respectively). The adjusted survival by Cox regression analysis was not significantly different (P=.25). However, patients with preserved LVF had fewer rehospitalizations for heart failure (25% vs 35%, P<.05). Predictors of mortality in the whole group by multivariate analysis were age, diabetes, chronic renal failure, atrial fibrillation, residence in a nursing home, and serum sodium < or = 135 mEq/L.
CONCLUSION: The prognosis of patients with clinical heart failure with or without preserved LVF is poor. Better treatment modalities are needed in both subsets.

Entities:  

Mesh:

Year:  2008        PMID: 18954847     DOI: 10.1016/j.amjmed.2008.06.031

Source DB:  PubMed          Journal:  Am J Med        ISSN: 0002-9343            Impact factor:   4.965


  7 in total

1.  Clinical observation on the treatment of atrial fibrillation with amiodarone combined with Shenmai Injection (参麦注射液).

Authors:  Min Deng; Xiang-qian Sui; Shi-bing Zhu; Wei Ma; Ying Xu; Zhi-ming Chen
Journal:  Chin J Integr Med       Date:  2010-09-25       Impact factor: 1.978

Review 2.  Myocardial ischemia in patients with diastolic dysfunction and heart failure.

Authors:  Thomas E Vanhecke; Robert Kim; Shaheena Z Raheem; Peter A McCullough
Journal:  Curr Cardiol Rep       Date:  2010-05       Impact factor: 2.931

3.  Hyponatremia as a prognostic and predictive factor in metastatic renal cell carcinoma.

Authors:  A N Jeppesen; H K Jensen; F Donskov; N Marcussen; H von der Maase
Journal:  Br J Cancer       Date:  2010-02-09       Impact factor: 7.640

4.  Heart failure and preserved left ventricular function: long term clinical outcome.

Authors:  Israel Gotsman; Donna Zwas; Chaim Lotan; Andre Keren
Journal:  PLoS One       Date:  2012-07-19       Impact factor: 3.240

5.  Electrocardiographic characteristics in patients with heart failure and normal ejection fraction: A systematic review and meta-analysis.

Authors:  Theodora Nikolaidou; Nathan A Samuel; Carl Marincowitz; David J Fox; John G F Cleland; Andrew L Clark
Journal:  Ann Noninvasive Electrocardiol       Date:  2019-10-11       Impact factor: 1.468

6.  Low serum albumin: A significant predictor of reduced survival in patients with chronic heart failure.

Authors:  Israel Gotsman; Ayelet Shauer; Donna R Zwas; Ilgar Tahiroglu; Chaim Lotan; Andre Keren
Journal:  Clin Cardiol       Date:  2019-02-07       Impact factor: 2.882

7.  Serum albumin and the short-term mortality in individuals with congestive heart failure in intensive care unit: an analysis of MIMIC.

Authors:  Peng Chao; Xinyue Cui; Shanshan Wang; Lei Zhang; Qingru Ma; Xueqin Zhang
Journal:  Sci Rep       Date:  2022-09-28       Impact factor: 4.996

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.